Skip to main content

Table 1 Clinical and demographic data of the patient cohorts profiled for expression of obesity-related genes

From: Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease

Demographic or clinical parameter Mean ± SD, or %
(N = 24)
BMI (*) 47.96 ± 8.2
AST, (U/L) (*) 24.92 ± 8.37
ALT, (U/L) (*) 30.38 ± 12.88
Total cholesterol, mg/dL (*) 205.08 ± 41.82
HDL, mg/dL (*) Females 50.33 ± 11.85
HDL, mg/dL (*) Males 39.66 ± 41.82
Triglyceride, mg/dL (*) 197 ± 105.39
Age 43.93 ± 10.2
Gender (Females) 79% (N = 19)
Race (caucasian) 67% (N = 16)
Advanced inflammation (score ≥ 3) 54% (N = 13)
NASH 63% (N = 15)
Advanced steatosis 42% (N = 10)
Fibrosis 79% (N = 19)
Steatosis with presence of hepatic inflammation 96% (N = 23)
NASH with presence of hepatic inflammation 62.5% (N = 15)
  1. Values marked by asterisk (*) are given as Mean ± SD. SD: standard deviation; BMI: Body Mass Index; NASH: Non-Alcoholic Steatohepatitis; AST: aspartate aminotransferase; ALT: Alanine transaminase; HDL: High-density lipoprotein.